This technology is a variant, mutant, or modulator of the synaptic chaperon protein Hspa8 which potentiates neurotransmission to suppress spinal muscular atrophy (SMA) phenotypes with further applications in other neurogenerative diseases including Amyotrophic Lateral Sclerosis (ALS) and tau-related dementias.
